1. Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute

   • Xavier Rossello
   • Zhenhe He
   • Derek M. Yellon

   SHORT COMMUNICATION Open access 14 April 2018 Pages: 127 - 133

   

2. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes

   • Yochai Birnbaum
   • Mandeep Bajaj
   • Yumei Ye

   ORIGINAL ARTICLE 05 March 2018 Pages: 135 - 145

   

3. Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats

   • Ramoji Kosuru
   • Vidya Kandula
   • Sanjay Singh

   ORIGINAL ARTICLE 20 March 2018 Pages: 147 - 163

   

4. The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway

   • Helison Do Carmo
   • Sapna Arjun
   • Sean M Davidson

   SHORT COMMUNICATION Open access 26 March 2018 Pages: 165 - 168

   

5. Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart

   • Bartłomiej Jacek Bińkowski
   • Marcin Makowski
   • Andrzej Lubiński

   ORIGINAL ARTICLE Open access 06 April 2018 Pages: 169 - 173

   

6. Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials

   • Harold E. Bays
   • Robert S. Rosenson
   • G. Kees Hovingh

   SHORT COMMUNICATION Open access 07 April 2018 Pages: 175 - 180

   

7. Correction to: Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials

   • Harold E. Bays
   • Robert S. Rosenson
   • G. Kees Hovingh

   Correction 27 April 2018 Pages: 181 - 181

8. An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER)

   • Fumiki Yoshihara
   • Miki Imazu
   • on behalf of the DAPPER investigators and study coordinators

   ORIGINAL ARTICLE 28 March 2018 Pages: 183 - 190

   

9. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry

   • Ioanna Xanthopoulou
   • Vasiliki-Maria Dragona
   • for the GRAPE-AF Investigators

   ORIGINAL ARTICLE 20 April 2018 Pages: 191 - 196

10. Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies

    • Liesa K. Hoppe
    • Dana C. Muhlack
    • Ben Schöttker

    REVIEW ARTICLE 20 April 2018 Pages: 197 - 212

    

11. Do the SGLT-2 Inhibitors Offer More than Hypoglycemic Activity?

    • Eduardo Flores
    • Carlos G. Santos-Gallego
    • Juan Jose Badimon

    REVIEW ARTICLE 20 April 2018 Pages: 213 - 222

    

12. Old Drugs for New Indications in Cardiovascular Medicine

    • Yaron Arbel
    • Wael Abuzeid
    • Michael E. Farkouh

    REVIEW ARTICLE 10 April 2018 Pages: 223 - 232

    

13. Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease

    • Soo-Sang Kang
    • Robert S. Rosenson

    REVIEW ARTICLE 20 April 2018 Pages: 233 - 240